Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2006, Vol. 11 ›› Issue (9): 1013-1016.

Previous Articles     Next Articles

Targeting multiple signaling pathways in LNCaP prostate cancer cell line by trichostatin A

SUN Sheng-kun1,2, LIU Bing1, LI Xiu-shen1, HOU Chun-mei1, HONG Bao-fa2, YU Xiao-dan1   

  1. 1Institute of Basic Medical Sciences, Academy ofMilitary Medical Sciences, Beijing 100850 , China;
    2Department of Urology , PLA General Hospital, Beijing 100853, China
  • Received:2006-04-03 Revised:2006-06-15 Online:2006-09-26 Published:2020-11-05

Abstract: AIM: To investigate the molecular mechanisms underlying the antitumor effect of trichostatin A (TSA) on LNCaP prostate cancer cells.METHODS: Colony formation analysis was performed to assay the effect of TSA on LNCaP colony forming ability.Western blotting was used to analyze protein acetylation standard as well as the expression of a panel of signaling molecules after TSA exposure.RESULTS: TSA inhibited the colony forming ability of LNCaP cells at a very low concentration.TSA exposure caused elevated acetylation of total cellular proteins as well as accumulation of acetylated-H3.In addition, signaling molecules which play key roles in prostate cancer such as AR, ErbB2, Raf-1,CDK4, and Akt were depleted by TSA in a dose and time-dependent manner.CONCLUSION: TSA exhibits significant antitumor activity against LNCaP cells by simultaneously interfering with multiple signaling pathways such as HER2/MAPK, AR, and PI-3K-AKT pathways.

Key words: histone deacetylase, prostate cancer, signal transduction pathway, cell apoptosis, histone deacetylase inhibitors, trichostatin A

CLC Number: